Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Merck and Siemens Partner to Drive AI and Data-Led Drug Development
Wednesday, September 24, 2025Merck has signed a new Memorandum of Understanding MoU with Siemens to expand their strategic partnershipThe collaboration aims to accelerate digital transformation in the life sciences sector by integrating software systems and consumables that use...
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Advance Breast and Prostate Cancer Detection
Tuesday, September 23, 2025SOPHiA GENETICS has announced an expanded partnership with AstraZeneca to improve the detection and treatment of breast and prostate cancerThe announcement was made at the World CB CDx Summit in Boston
Sanofi’s SAR446268 Gene Therapy Receives US Fast Track Designation for Non-Congenital Myotonic Dystrophy Type 1
Tuesday, September 23, 2025Sanofi has received Fast Track designation from the US Food and Drug Administration FDA for its investigational therapy SAR developed for juvenile and adult noncongenital myotonic dystrophy type DM
Starpharma Enters into Collaboration and Agreement with Genentech for Cancer Therapy Development
Tuesday, September 23, 2025Starpharma has entered into a collaboration and licence agreement with Genentech to develop cancer therapies using Starpharmas DEP drug delivery technology
FUJIFILM Biotechnologies Expands Partnership with argenx to Include U.S. Manufacturing
Friday, September 19, 2025FUJIFILM Biotechnologies has expanded its global partnership with argenx SE to include drug substance manufacturing operations in the United States
Minovia Therapeutics gains FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome
Friday, September 19, 2025Minovia Therapeutics has received Fast Track Designation from the US Food and Drug Administration FDA for its lead investigational therapy MNV in Myelodysplastic Syndrome MDS
Roche to Acquire 89bio for the Treatment of Moderate to Severe MASH
Thursday, September 18, 2025Roche has signed a definitive agreement to acquire bioMetabolic dysfunctionassociated steatohepatitis MASH is a progressive form of fatty liver disease linked to obesity and type diabetes It affects an estimated of the global adult population
Wheeler Bio and MindImmune Therapeutics partners to advance Alzheimer’s prevention programme MITI-101
Thursday, September 18, 2025Wheeler Bio has entered into an agreement with MindImmune Therapeutics to support the development of its lead Alzheimers prevention programme MITIMITI is a monoclonal antibody aimed at blocking CDc immune cell recruitment from the blood into the brai...
Deciphera Receives Approval for ROMVIMZA™ (vimseltinib) in Tenosynovial Giant Cell Tumour (TGCT)
Thursday, September 18, 2025Deciphera Pharmaceuticals has received approval from the European Commission EC for ROMVIMZA vimseltinib to treat adult patients with symptomatic tenosynovial giant cell tumour TGCT in the European Union
Adagene Enters into Collaboration with Exelixis to Develop Third Masked Antibody-Drug Conjugate
Wednesday, September 17, 2025Adagene has expanded its collaboration and licence agreement with Exelixis to include a third antibodydrug conjugate ADC
